Plant-Based Diets Linked to Lower Mortality in CKD

This article originally appeared here.
Share this content:
Plant-Based Diets Linked to Lower Mortality in CKD
Plant-Based Diets Linked to Lower Mortality in CKD

MONDAY, Dec. 14, 2015 (HealthDay News) -- A diet high in plant protein intake is associated with lower all-cause mortality in individuals with chronic kidney disease (CKD), according to research published online Dec. 10 in the American Journal of Kidney Disease.

Xiaorui Chen, of the University of Utah in Salt Lake City, and colleagues conducted an observational study using dietary recall and mortality data for 14,866 participants (aged 20 years or older) in the NHANES III to examine the association between plant protein intake and all-cause mortality. Patients were stratified according to estimated glomerular filtration rate (eGFR) <60 or ≥60 mL/min/1.73 m².

The researchers found that plant protein intake and plant protein to total protein ratio averaged 24.6 ± 13.2 g/d and 33.0 ± 14.0 percent, respectively. The prevalence of eGFR <60 mL/min/1.73 m² in this population was 4.9 percent. Following multivariable adjustment, each 33 percent increase in the plant protein to total protein ratio was not associated with mortality (hazard ratio [HR], 0.88; 95 percent confidence interval, 0.74 to 1.04) in those with eGFR ≥60 mL/min/1.73 m², but it was associated with lower mortality risk (hazard ratio, 0.77; 95 percent confidence interval, 0.61 to 0.96) in those with eGFR <60 mL/min/1.73 m².

"In conclusion, this study suggests that a higher proportion of protein from plant sources is associated with lower mortality in patients with CKD," the authors write.

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Permits Marketing of Brain Stimulation Device for OCD

FDA Permits Marketing of Brain Stimulation Device for ...

FDA previously approved transcranial magnetic stimulation for major depression, certain migraines

Comments Open on End of NIH Review for Gene Therapy Studies

Comments Open on End of NIH Review for ...

NIH oversight panel no longer plans to review all applications for gene therapy experiments

U.S. Measles Outbreak Hits 107 Cases in 21 States, D.C.

U.S. Measles Outbreak Hits 107 Cases in 21 ...

Outbreak on track to exceed last year's; most of the people who got measles weren't vaccinated

is free, fast, and customized just for you!




Already a member?

Sign In Now »